Evolution of MET and NRAS gene amplification as acquired resistance mechanisms in EGFR mutant NSCLCTara L. Peters, Robert C. Doebele|npj Precision Oncology|2021Cited by 11
Intrinsic resistance to <scp>ROS1</scp> inhibition in a patient with <scp><i>CD74‐ROS1</i></scp> mediated by <scp>AXL</scp> overexpressionTara L. Peters, Robert C. Doebele|Thoracic Cancer|2023Cited by 2